Owkin

French tech company | Builders Republic

About

AI platform for biomedical R&D that uses federated learning to train models on distributed patient data without centralizing sensitive records — enabling drug discovery, clinical trial optimization, and patient stratification for pharmaceutical companies and hospitals, via its K Pro AI agent.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Extension
Founded
2016
City
PARIS
Region
IDF
Tracked rounds
7
Amount raised
274 M€ raised since 2020

Recognition

  • Unicorn since 2021-11 (1.0 bn$)

Funding rounds

  • Extension · 2022
  • Series B · 2021
  • Extension · 2020
  • Extension · 2020
  • Extension · 2019
  • Series A · 2018
  • Seed · 2016

Investors